Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

146.34
+0.66000.45%
Post-market: 146.340.00000.00%18:16 EDT
Volume:6.59M
Turnover:963.52M
Market Cap:181.56B
PE:-55.96
High:147.22
Open:144.23
Low:143.18
Close:145.68
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:1.32
T/O Rate:0.53%
Dividend:3.22
Dividend Rate:2.20%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.35
PE(LYR):21.58

Loading ...

Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000

Reuters
·
Aug 06

Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says

MT Newswires Live
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Staar Surgical (STAA) and Elanco Animal Health (ELAN)

TIPRANKS
·
Aug 06

Gilead Sciences Inc Stock (GILD) Moved Down by 3.96% on Aug 5: A Full Analysis

TradingKey
·
Aug 06

Gilead Sciences (GILD) Faces Fresh HIV Access Criticism From AIDS Healthcare Foundation

Simply Wall St.
·
Aug 05

Movement Alert|Gilead Sciences Falls 3.03% in Regular Trading, Q2 Acquisition-Driven R&D Charges Swing Results to Loss Despite Revenue Beat

Market Focus
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Ultragenyx Pharmaceutical (RARE) and Beam Therapeutics (BEAM)

TIPRANKS
·
Aug 05

RBC Capital Adjusts Gilead Sciences Price Target to $123 From $120, Maintains Sector Perform Rating

MT Newswires Live
·
Aug 05

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Kymera Therapeutics Q2 Collaboration Revenue More than Doubles, Beats Estimates

Reuters
·
Aug 05

Gilead : Leerink Partners Raises Target Price to $130 from $126

THOMSON REUTERS
·
Aug 05

Gilead Sciences (GILD) Gets a Buy from Wells Fargo

TIPRANKS
·
Aug 05

Gilead Buy Rating Reaffirmed on Strong HIV-Driven Growth and Raised Revenue Outlook; $170 Price Target Maintained

TIPRANKS
·
Aug 05

Street View: Gilead's HIV Strength Outshines Long-Term Competitive Worries

Reuters
·
Aug 05

U.S. Research Roundup-Ametek, Ball Corp, McDonald's

Reuters
·
Aug 05

Switzerland's Sandoz H1 Net Sales Rise on Biosimilar Growth

Reuters
·
Aug 05

Gilead : Truist Securities Cuts Target Price to $150 from $156

THOMSON REUTERS
·
Aug 05

Gilead Corrects Q2 2026 Europe Odefsey Sales to $58 Million

Reuters
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Gilead Forecasts FY26 Yeztugo Revenue at About $1 Billion

Reuters
·
Aug 05